CME

Neovascular Age-related Macular Degeneration: Emerging Therapies With an EYE On Treatment Frequency

Neovascular Age-related Macular Degeneration: Emerging Therapies With an EYE On Treatment Frequency

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

Overview

CME Information

page 1 of 8